EUVIMEDOpdag EUVIMED
Open access

S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects

Gloria Ursino iD, Giulia Lucibello iD, Pryscila D S Teixeira, Anna Höfler iD, Christelle Veyrat-Durebex iD, Soline Odouard, Florian Visentin, Luca Galgano, Emmanuel Somm, Claudia R Vianna, Ariane Widmer, François R Jornayvaz iD and 3 more

Science Advances · 2024-01-05 · 10 (1)

DOI: 10.1126/sciadv.adj4686 ↗

At a glance

Journal article in Science Advances, published on 2024-01-05. Written by Gloria Ursino and 14 co-authors. Institution: Department of Cell Physiology and Metabolism, University of Geneva, 1211 Geneva, Switzerland. Major MEDLINE topics: Diabetes Mellitus, Type 1, Hypoglycemia, Hyperglycemia. Cited 16 times so far (Crossref); 88 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Type 1 diabetes mellitus (T1DM) is characterized by insulin deficiency leading to hyperglycemia and several metabolic defects. Insulin therapy remains the cornerstone of T1DM management, yet it increases the risk of life-threatening hypoglycemia and the development of major comorbidities. Here, we report an insulin signaling–independent pathway able to improve glycemic control in T1DM rodents. Co-treatment with recombinant S100 calcium-binding protein A9 (S100A9) enabled increased adherence to glycemic targets with half as much insulin and without causing hypoglycemia. Mechanistically, we demonstrate that the hyperglycemia-suppressing action of S100A9 is due to a Toll-like receptor 4–dependent increase in glucose uptake in specific skeletal muscles (i.e., soleus and diaphragm). In addition, we found that T1DM mice have abnormal systemic inflammation, which is resolved by S100A9 therapy alone (or in combination with low insulin), hence uncovering a potent anti-inflammatory action of S100A9 in T1DM. In summary, our findings reveal the S100A9-TLR4 skeletal muscle axis as a promising therapeutic target for improving T1DM treatment.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 1HypoglycemiaHyperglycemiaAnimalsMiceInsulinHypoglycemic AgentsCalgranulin B

Substances

InsulinHypoglycemic AgentsS100A9 protein, mouseCalgranulin B

Authors and institutions

  • Department of Cell Physiology and Metabolism, University of Geneva, 1211 Geneva, Switzerland.
  • Diabetes Center of the Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
  • Department of Molecular Biology, University of Geneva, 1211 Geneva, Switzerland.
  • Service of Endocrinology, Diabetes, Nutrition and Therapeutic patient education, Geneva University Hospital, 1205 Geneva, Switzerland.
  • Center for Hypothalamic Research, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.

ORCID profiles: Gloria Ursino, Giulia Lucibello, Anna Höfler, Christelle Veyrat-Durebex, François R Jornayvaz, Andreas Boland, Giorgio Ramadori, Roberto Coppari

Cite

APA

Ursino, G., Lucibello, G., Teixeira, P. D. S., Höfler, A., Veyrat-Durebex, C., Odouard, S., Visentin, F., Galgano, L., Somm, E., Vianna, C. R., Widmer, A., Jornayvaz, F. R., Boland, A., Ramadori, G., & Coppari, R. (2024). S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects. Science Advances, 10(1). https://doi.org/10.1126/sciadv.adj4686

Vancouver

Ursino G, Lucibello G, Teixeira PDS, Höfler A, Veyrat-Durebex C, Odouard S, et al. S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects. Science Advances. 2024;10(1). doi:10.1126/sciadv.adj4686

BibTeX
@article{Ursino2024,
  author = {Ursino, Gloria and Lucibello, Giulia and Teixeira, Pryscila D S and Höfler, Anna and Veyrat-Durebex, Christelle and Odouard, Soline and Visentin, Florian and Galgano, Luca and Somm, Emmanuel and Vianna, Claudia R and Widmer, Ariane and Jornayvaz, François R and Boland, Andreas and Ramadori, Giorgio and Coppari, Roberto},
  title = {S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {1},
  doi = {10.1126/sciadv.adj4686}
}
Start for free →